Evoke Pharma Inc. (NASDAQ: EVOK)
$0.52
-0.0660 ( -11.20% ) 7.9K
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Market Data
Open
$0.52
Previous close
$0.59
Volume
7.9K
Market cap
$4.91M
Day range
$0.56 - $0.60
52 week range
$0.40 - $1.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
ars/a | Annual reports | 1 | May 14, 2024 |
10-q | Quarterly Reports | 39 | May 14, 2024 |
8-k | 8K-related | 13 | May 14, 2024 |
10-k/a | Quarterly Reports | 69 | May 14, 2024 |
def | Proxies and info statements | 19 | Apr 10, 2024 |
ars | Annual reports | 1 | Apr 10, 2024 |
pre | Proxies and info statements | 18 | Mar 29, 2024 |
8-k | 8K-related | 12 | Mar 25, 2024 |
8-k | 8K-related | 11 | Mar 21, 2024 |
8-k | 8K-related | 11 | Mar 18, 2024 |